Cargando…
Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
Autores principales: | Zahedifard, Farnaz, Lee, Hyeryon, No, Joo Hwan, Salimi, Mona, Seyed, Negar, Asoodeh, Ahmad, Rafati, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634371/ https://www.ncbi.nlm.nih.gov/pubmed/31310603 http://dx.doi.org/10.1371/journal.pntd.0007584 |
Ejemplares similares
-
Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019) -
Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate
por: Dabirian, Sara, et al.
Publicado: (2013) -
An Overview of Brevinin Superfamily: Structure, Function and Clinical Perspectives
por: Savelyeva, Anna, et al.
Publicado: (2014) -
Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
por: Seyed, Negar, et al.
Publicado: (2022) -
Brevinin-2R-linked polyethylenimine as a promising hybrid nano-gene-delivery vector
por: Zohrab, Fatemeh, et al.
Publicado: (2019)